Skip to content

Public FDA record

Z-1064-2014: SL & SLi Series (Mod 15/18/20/25) Linear Accelerator Used for radiation therapy treatments of malignant

Recall record Z-1064-2014 for Elekta, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1064-2014
Company in FDA record
Elekta, Inc.
FDA classification date
Mar 14, 2014
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Customers are resetting the default values outside recommended factory settings.

Source facts

Action
The firm, Elekta, sent an "Important Field Safety Notice (IFSN 200 01 103 073 - Electron Applicator Auto-Tracking Defaults)" released on May 28, 2013 and is in the process of being distributed to all customers. The Notice requests users to please adhere to the instructions and advice given in manuals and system dialogues, which explicitly state that a change to auto-tracking values could compromise compliance with safety standards and can cause increased unwanted radiation dose to the patient. All machines should be checked against the default settings attached. If the actual settings are greater than the default settings, then Elekta's recommendation is that the default settings should b re-applied and all relevant physics checks (e.g. beam uniformity, output factor) performed. If, however, auto-tracking values are increased beyond their factory-set defaults, then electron applicator radiation leakage measurements should also be made to ensue that the system remains compliant to IEC safety. All users of Desktop Pro and Integrity 1.1 software will receive a mandatory upgrade to Integrity 1.2 (released 28-Jan-14. The upgrade path to Integrity 1.2 differs depending on system configurations at each customers site, therefore Elekta has released three separate Important Field Safety Modifications in order to upgrade all customers successfully. Important Field Safety Notice 200 01 501 036 Important Field Safety Modifications 200 02 501 037 Applicable System Configuration Desktop Pro with Fast Tuning Magnetron, New Patient Support System; Important Field Safety Notice 200 01 501 038 Important Field Safety Modification 200 02 501 039 Applicable System Configuration Desktop Pro with Linac Control System MK3i, Fast Tuning Magnetron, New Patient Support System; Important Field Safety Notice 200 01 502 035 Important Field Safety Modification 200 02 502 036 Applicable System Configuration All Integrity 1.1 sites. All users of Integrity 3.1 will receive a man
Initiated
2013-05-28
Root cause
Device Design
Terminated
2017-01-17
Distribution
Worldwide Distribution: US (Nationwide) including states of: AK, CA, CT, FL, IL, IN, IA, LA, MD, MA, MI, MN, NJ, NY, OH, OK, OR, PA, TN, TX, VA, WA, WV, and Puerto Rico; and countries of: Argentina, Australia, Austria, Belarus, Belgium, Bosnia & Herzegovinia, Brazil, Canada, China, Czech Republic, Denmark, France, Germany, Greece, Hong Kong, Hungary, India, Indonesia, Iran, Ireland, Italy, Japan, Jordan, Libya, Mexico, Netherlands, New Zealand, Norway, Panama, Philippines, Poland, Portugal, Russia, Senegal, Serbia, Singapore, Slovenia, South Africa, Spain, Sudan, Sweden, Switzerland, Taiwan, Turkey, and United Kingdom.
Recall number
Z-1064-2014
Recall status
Terminated
CDRH record ID
118950
FDA classified
2014-03-14
Recall event number
65450

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗